Dr. Wenwei Huang is the Medicinal Chemistry group leader at the Therapeutic Development Branch within NCATS' Division of Preclinical Innovation. He has worked in various therapeutic areas, including oncology, neurological disorders, inflammation and infectious diseases. In addition to drug discovery and development program, he is interested in developing technology platform to facilitate translational research.